ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 (ST3GAL5) Peptid
ST3GAL5
Reaktivität: Säugetier
Wirt: Synthetic
BP, IHC, WB
Produktnummer ABIN937546
Kurzübersicht für ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 (ST3GAL5) Peptid (ABIN937546)
Target
ST3GAL5
(ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 (ST3GAL5))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- DSEAESKYDP PFGFRKFSSK VQTLLELLPE HDLPEHLKAK TCRRCVVIGS
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ST3 GAL5 antibody,
Alternative Names: ST3GAL5 control peptide, ST3GAL5 antibody Blocking Peptide, Anti-ST3GAL5 Blocking Peptide, St3 Beta-Galactoside Alpha-23-Sialyltransferase 5 Blocking Peptide, SIAT9 Blocking Peptide, SIATGM3S Blocking Peptide, ST3GalV Blocking Peptide, ST3GAL5, STGAL5-3, STGAL5 3, STGAL5-3 Blocking Peptide, STGAL5 3 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- ST3GAL5 (ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 (ST3GAL5))
-
Hintergrund
- Ganglioside GM3 is known to participate in the induction of cell differentiation, modulation of cell proliferation, maintenance of fibroblast morphology, signal transduction, and integrin-mediated cell adhesion. ST3GAL5 is a type II membrane protein which catalyzes the formation of GM3 using lactosylceramide as the substrate. It is a member of glycosyltransferase family 29 and may be localized to the Golgi apparatus. Mutation in its gene has been associated with Amish infantile epilepsy syndrome.
-
Molekulargewicht
- 48 kDa
Target
-
Sie sind hier:
